591 related articles for article (PubMed ID: 16950041)
1. The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis.
Gill JB; Rosenstein A
J Arthroplasty; 2006 Sep; 21(6):869-73. PubMed ID: 16950041
[TBL] [Abstract][Full Text] [Related]
2. Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic acid.
Colomina MJ; Bagó J; Vidal X; Mora L; Pellisé F
Orthopedics; 2009 Feb; 32(2):91. PubMed ID: 19301800
[TBL] [Abstract][Full Text] [Related]
3. Tranexamic acid reduces blood loss and blood transfusions in primary total hip arthroplasty: a prospective randomized double-blind study in 40 patients.
Husted H; Blønd L; Sonne-Holm S; Holm G; Jacobsen TW; Gebuhr P
Acta Orthop Scand; 2003 Dec; 74(6):665-9. PubMed ID: 14763696
[TBL] [Abstract][Full Text] [Related]
4. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
5. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery.
Brown JR; Birkmeyer NJ; O'Connor GT
Circulation; 2007 Jun; 115(22):2801-13. PubMed ID: 17533182
[TBL] [Abstract][Full Text] [Related]
7. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
[TBL] [Abstract][Full Text] [Related]
8. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied.
Alvarez JC; Santiveri FX; Ramos I; Vela E; Puig L; Escolano F
Transfusion; 2008 Mar; 48(3):519-25. PubMed ID: 18067499
[TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
[TBL] [Abstract][Full Text] [Related]
11. Tranexamic acid reduces blood loss in cemented hip arthroplasty: a randomized, double-blind study of 39 patients with osteoarthritis.
Niskanen RO; Korkala OL
Acta Orthop; 2005 Dec; 76(6):829-32. PubMed ID: 16470437
[TBL] [Abstract][Full Text] [Related]
12. Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures using tranexamic acid or aprotinin? A comparative study with controls.
Baldus CR; Bridwell KH; Lenke LG; Okubadejo GO
Spine (Phila Pa 1976); 2010 Jan; 35(2):235-9. PubMed ID: 20081519
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid in total hip arthroplasty saves blood and money: a randomized, double-blind study in 100 patients.
Johansson T; Pettersson LG; Lisander B
Acta Orthop; 2005 Jun; 76(3):314-9. PubMed ID: 16156456
[TBL] [Abstract][Full Text] [Related]
14. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement.
Rajesparan K; Biant LC; Ahmad M; Field RE
J Bone Joint Surg Br; 2009 Jun; 91(6):776-83. PubMed ID: 19483232
[TBL] [Abstract][Full Text] [Related]
15. The use of tranexamic acid to reduce blood loss during total hip arthroplasty: an observational study.
Hynes MC; Calder P; Rosenfeld P; Scott G
Ann R Coll Surg Engl; 2005 Mar; 87(2):99-101. PubMed ID: 15826417
[TBL] [Abstract][Full Text] [Related]
16. Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement.
Lemay E; Guay J; Côté C; Roy A
Can J Anaesth; 2004 Jan; 51(1):31-7. PubMed ID: 14709457
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery.
Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM
Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082
[TBL] [Abstract][Full Text] [Related]
18. Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials.
Zhou XD; Tao LJ; Li J; Wu LD
Arch Orthop Trauma Surg; 2013 Jul; 133(7):1017-27. PubMed ID: 23615973
[TBL] [Abstract][Full Text] [Related]
19. Minimising blood loss and transfusion in contemporary hip and knee arthroplasty.
Watts CD; Pagnano MW
J Bone Joint Surg Br; 2012 Nov; 94(11 Suppl A):8-10. PubMed ID: 23118371
[TBL] [Abstract][Full Text] [Related]
20. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials.
Cid J; Lozano M
Transfusion; 2005 Aug; 45(8):1302-7. PubMed ID: 16078916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
